ArticleFrontiers in pharmacology2022

Avasimibe Alleviates Disruption of the Airway Epithelial Barrier by Suppressing the Wnt/β-Catenin Signaling Pathway.

Zicong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.